Grace Therapeutics
GRCE
#9768
Rank
A$76.84 M
Marketcap
A$4.97
Share price
-1.49%
Change (1 day)
-18.82%
Change (1 year)

Earnings for Grace Therapeutics (GRCE)

Earnings in 2025 (TTM): -A$19.58 Million

According to Grace Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$24.67 Million, an increase over its 2023 earnings that were of -A$72.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Grace Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.58 Million-20.66%
2024 -A$24.67 Million-66.16%
2023 -A$72.91 Million161.72%
2022 -A$27.86 Million60.58%
2021 -A$17.35 Million-462.11%
2020 A$4.79 M-107.63%
2019 -A$62.77 Million66.34%
2018 -A$37.74 Million
2016 -A$8.33 Million36.04%
2015 -A$6.12 Million192.45%
2014 -A$2.1 Million-85.94%
2013 -A$14.88 Million49.55%
2012 -A$9.95 Million